SPRO (Spero Therapeutics, Inc. Common Stock) Stock Analysis - Community

Spero Therapeutics, Inc. Common Stock (SPRO) is a publicly traded Healthcare sector company. As of May 21, 2026, SPRO trades at $2.64 with a market cap of $149.39M and a P/E ratio of 0.00. SPRO moved +1.16% today. Year to date, SPRO is +8.23%; over the trailing twelve months it is +286.65%. Its 52-week range spans $0.51 to $3.22. Rallies surfaces SPRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade SPRO?

Rallies community data for SPRO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

SPRO Key Metrics

Key financial metrics for SPRO
MetricValue
Price$2.64
Market Cap$149.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.22
52-Week Low$0.51
Volume2.08K
Avg Volume0
Revenue (TTM)$13.51M
Net Income$-525.95K
Gross Margin57.80%

Latest SPRO News

Recent SPRO Insider Trades

  • Rajavelu Esther sold 25.24K (~$63.35K) on May 4, 2026.
  • Rajavelu Esther sold 37.10K (~$87.56K) on Feb 6, 2026.
  • Rajavelu Esther sold 50.82K (~$119.93K) on Feb 6, 2026.

SPRO Analyst Consensus

SPRO analyst coverage data. Average price target: $0.00.

Common questions about SPRO

How does the Rallies community trade SPRO?
Rallies community data for SPRO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for SPRO?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for SPRO when enough community data is available.
Is SPRO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SPRO. It does not provide personalized investment advice.
SPRO

SPRO